Edward Metzger
13Patents
1h-index
52Co-inventors
53Inventor score
Filing activity: Jun 16, 2000 → Feb 2, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6399640B1 | Arylthiazolidinedione and aryloxazolidinedione derivatives | Chemistry; Metallurgy | 2 | Expired |
| US10011615B2 | Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties | Chemistry; Metallurgy | 1 | Active |
| US8648058B2 | Diazeniumdiolate cyclopentyl derivatives | Chemistry; Metallurgy | 1 | Active |
| US10822338B2 | Substituted aminoquinazoline compounds as A2A antagonist | Chemistry; Metallurgy | 1 | Active |
| US8318667B2 | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use | Human Necessities | 1 | Active |
| US6380191B1 | Arylthiazolidinedione and aryloxazolidinedione derivatives | Chemistry; Metallurgy | 1 | Expired |
| US6465497B2 | Arylthiazolidinedione derivatives | Chemistry; Metallurgy | 0 | Expired |
| US11046714B2 | 2,2-difluorodioxolo A2A receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US8324384B2 | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use | Human Necessities | 0 | Active |
| US9745282B2 | Indoline compounds as aldosterone synthase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9550750B2 | Indoline compounds as aldosterone synthase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9108920B2 | Diazeniumdiolate heterocyclic derivatives | Chemistry; Metallurgy | 0 | Active |
| US8436015B2 | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.